HSCS — HeartSciences Balance Sheet
0.000.00%
- $3.89m
- $3.82m
- $0.02m
- 22
- 13
- 67
- 26
Annual balance sheet for HeartSciences, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.497 | 0.723 | 0.918 | 1.66 | 5.81 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 0.002 | 0 | — |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1.54 | 1.64 | 1.93 | 2.7 | 7.35 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.418 | 0.289 | 0.159 | 0.591 | 0.56 |
Net Intangible Assets | |||||
Total Assets | 1.96 | 1.93 | 2.09 | 3.29 | 9.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.14 | 1.25 | 3.47 | 1.83 | 1.75 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.64 | 3.84 | 8.15 | 3.06 | 2.19 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.316 | -1.91 | -6.06 | 0.231 | 7.32 |
Total Liabilities & Shareholders' Equity | 1.96 | 1.93 | 2.09 | 3.29 | 9.5 |
Total Common Shares Outstanding |